What is the Bio-Gene Technology (ASX: BGT) share price?
The BGT share price is $0.02, up 0.00% for the day, based on the latest available ASX market data.
What is Bio-Gene Technology's market capitalisation?
Bio-Gene Technology has a market capitalisation of $5.4M, making it the 1634th-largest security listed on the ASX.
Does Bio-Gene Technology pay a dividend?
BGT does not currently have a dividend on record. Some companies, particularly those reinvesting in growth or not yet profitable, do not pay dividends.
Is Bio-Gene Technology profitable?
In its most recent reported period (ending 31 Dec 2025), BGT reported revenue of $0 and a net loss of $1.4M.
How many BGT shares are on issue?
Bio-Gene Technology has approximately 270,244,750 shares on issue, based on its market capitalisation of $5.4M and current share price.
What sector is Bio-Gene Technology in?
Bio-Gene Technology is classified in the Healthcare sector, within the Biotechnology industry on the ASX.
When did Bio-Gene Technology list on the ASX?
Bio-Gene Technology listed on the Australian Securities Exchange on 28 Nov 2017.
